Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05762705 · ClinicalTrials.gov registry record · NA
A Mobile Gaming App to Improve Adherence to PrEP
A NA study of HIV/AIDS and Medication Adherence, sponsored by Rhode Island Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 3
- Study locations
NCT05762705 is a NA study of HIV/AIDS and Medication Adherence that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 200 participants, below the 33,177-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05762705, a NA study of HIV/AIDS and Medication Adherence, is actively recruiting participants, sponsored by Rhode Island Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 3
- Study locations
Study Summary
In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in clinical settings in New England and Mississippi. Formative evaluation interviews will be conducted with stakeholders (healthcare workers, clinic administrators, and patients taking PrEP) to inform intervention delivery. Data from the formative interviews will also be used to make necessary adaptations to the game and assess acceptability for diverse populations and clinics. Viral Combat will then be further tested with 200 participants ages 15-34 years, receiving PrEP care at clinical sites in the South (n=100 Jackson, MS) and New England (n=100, Providence, RI; Boston, MA) in a multisite Hybrid Type 1 effectiveness-implementation randomized controlled trial (RCT). This trial will test the efficacy of the intervention compared to a control condition (a non-PrEP related game) on biological and behavioral measures. At the end of the trial, a summative evaluation of the implementation context using the i-PARIHS framework will occur. These interviews with study participants and clinic staff will inform future implementation and dissemination of Viral Combat.
Conditions Studied
Interventions
- BEHAVIORAL Multilevel Gaming Adherence Intervention
- BEHAVIORAL Treatment as Usual +
Study Locations (3)
Massachusetts
- Boston Medical Center - Boston
Mississippi
- University of Mississippi Medical Center - Jackson
Rhode Island
- Lifespan (The Miriam Hospital and Rhode Island Hospital) - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-21 |
| Est. Completion | 2027-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05762705
The ClinicalTrials.gov registry entry for NCT05762705 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,177-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Multilevel Gaming Adherence Intervention is the first listed.
NCT05762705 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Mississippi, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05762705 about?
NCT05762705 is a clinical study titled "A Mobile Gaming App to Improve Adherence to PrEP". In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in clinical settings in New England and Mississippi. Formative evaluation interviews will be conducted with stakeholders (healthc...
What is the current status of trial NCT05762705?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-21. Estimated completion is 2027-03-03.
What conditions does trial NCT05762705 study?
This clinical trial studies the following conditions: HIV/AIDS, Medication Adherence.
What interventions are being tested in trial NCT05762705?
The interventions under investigation include: Multilevel Gaming Adherence Intervention (BEHAVIORAL), Treatment as Usual + (BEHAVIORAL).
Who is sponsoring clinical trial NCT05762705?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05762705 being conducted?
This trial has 3 study locations across Massachusetts, Mississippi, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
-
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.